Two cases of nivolumab plus ipilimumab therapy for dialysis patients with advanced bone metastasis from renal cell carcinoma

Nivolumab and ipilimumab are immune checkpoint inhibitors. Combination therapy with these two drugs has been shown to improve the outcome of advanced renal cell carcinoma. However, data about the safety and the efficacy of combination therapy with these two drugs in hemodialysis patients are small....

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Mika, Takishita, Minika, Yamazato, Yukako, Kakinoki, Hiroaki, Udo, Kazuma, Tobu, Shohei, Noguchi, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151434/
https://www.ncbi.nlm.nih.gov/pubmed/36402939
http://dx.doi.org/10.1007/s13730-022-00753-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151434/
https://www.ncbi.nlm.nih.gov/pubmed/36402939
http://dx.doi.org/10.1007/s13730-022-00753-8

Ejemplares similares